O Positiv Expands CVS Range With Vaginal Health Capsules

O Positiv Health has expanded its product range at CVS Pharmacy, adding Vaginal Moisture Support Capsules, Vaginal Moisture Support Suppositories, and Ovarian Support Capsules to the Feminine Care aisle, per PRNewswire. The expansion builds on the brand's existing presence, which includes what it describes as the number-one best-selling vaginal probiotic in the United States, now stocked in over 6,000 CVS stores nationwide. The new listings went live in July 2026.

Why This Matters for Women's Health and the Microbiome

The vaginal microbiome is an area of growing scientific interest, closely linked to wider gut health research. Just as gut-brain connection studies have highlighted how microbial balance influences systemic wellbeing, researchers increasingly recognise that the vaginal microbiome — dominated by Lactobacillus species — plays a central role in women's reproductive and hormonal health. In the UK, microbiome UK research from institutions such as King's College London and the University of Reading has helped establish that probiotic interventions can support microbial diversity across multiple body sites, not solely the gut.

What O Positiv Is Adding to Shelves

According to PRNewswire, the three new products join O Positiv's existing CVS suite rather than replacing it. The Vaginal Moisture Support Capsules and Suppositories are designed to address vaginal dryness, while the Ovarian Support Capsules target ovarian health specifically. The brand's flagship vaginal probiotic — already established as the top seller in its category nationally, per the company's own claims — anchors the range. The expansion signals growing retail appetite for targeted women's health supplements that sit at the intersection of probiotic science and hormonal wellbeing.

The Gut–Vaginal Microbiome Connection

Scientists studying the gut-brain connection have long argued that microbial health cannot be viewed in isolation. The gut and vaginal microbiomes communicate via shared immune pathways, and disruption to one can influence the other. Research published by teams at University College London and Imperial College London has pointed to systemic inflammation as a common thread linking poor gut health and vaginal dysbiosis. Products designed to improve gut health naturally — including multi-strain probiotics — are increasingly being explored for their downstream effects on the vaginal microbiome, adding scientific context to the retail category O Positiv now occupies at scale.

What This Means for Health-Conscious Consumers

For consumers looking to support both gut health and vaginal health through evidence-informed supplementation, the O Positiv CVS expansion increases retail accessibility to targeted probiotic and hormonal support products. While the brand's growth is a US retail development, the underlying science — linking microbiome balance to women's systemic health — is equally relevant to health-conscious adults in the UK, where NHS gut health guidance is increasingly acknowledging the broader role of the microbiome.

O Positiv's CVS expansion reflects a broader market shift towards microbiome-informed women's health products. As research into the gut-brain connection and vaginal microbiome matures, retail ranges that bridge probiotic science with hormonal support are likely to grow on both sides of the Atlantic.

You might also like

• How to Improve Gut Health Naturally in 5 Steps
• Morinaga Milk Gains GRAS Status for Postbiotic Ingredient
• Fasting-Mimicking Diet Cuts Gum Disease Inflammation

96 Bacterial Strains. Two Shots a Day.

GOODIE is an award-winning fermented drink with 96 live bacterial strains — more than any yogurt or kombucha — never pasteurised, clinically tested, and 8 in 10 users felt less bloating within 14 days. Curious?

Find out more →